144 related articles for article (PubMed ID: 19809793)
1. Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in glioblastoma multiforme.
Persson O; Salford LG; Fransson J; Widegren B; Borrebaeck CA; Holmqvist B
J Neurooncol; 2010 Apr; 97(2):207-15. PubMed ID: 19809793
[TBL] [Abstract][Full Text] [Related]
2. The nuclear DNA repair protein Ku70/80 is a tumor-associated antigen displaying rapid receptor mediated endocytosis.
Fransson J; Borrebaeck CA
Int J Cancer; 2006 Nov; 119(10):2492-6. PubMed ID: 16929494
[TBL] [Abstract][Full Text] [Related]
3. 7B7: a novel antibody directed against the Ku70/Ku80 heterodimer blocks invasion in pancreatic and lung cancer cells.
O'Sullivan D; Henry M; Joyce H; Walsh N; Mc Auley E; Dowling P; Swan N; Moriarty M; Barnham P; Clynes M; Larkin A
Tumour Biol; 2014 Jul; 35(7):6983-97. PubMed ID: 24744142
[TBL] [Abstract][Full Text] [Related]
4. Ku70, a component of DNA-dependent protein kinase, is a mammalian receptor for Rickettsia conorii.
Martinez JJ; Seveau S; Veiga E; Matsuyama S; Cossart P
Cell; 2005 Dec; 123(6):1013-23. PubMed ID: 16360032
[TBL] [Abstract][Full Text] [Related]
5. MRP3: a molecular target for human glioblastoma multiforme immunotherapy.
Kuan CT; Wakiya K; Herndon JE; Lipp ES; Pegram CN; Riggins GJ; Rasheed A; Szafranski SE; McLendon RE; Wikstrand CJ; Bigner DD
BMC Cancer; 2010 Sep; 10():468. PubMed ID: 20809959
[TBL] [Abstract][Full Text] [Related]
6. Proteomic identification of Ku70/Ku80 autoantigen recognized by monoclonal antibody against hepatocellular carcinoma.
Luk JM; Su YC; Lam SC; Lee CK; Hu MY; He QY; Lau GK; Wong FW; Fan ST
Proteomics; 2005 May; 5(7):1980-6. PubMed ID: 15832367
[TBL] [Abstract][Full Text] [Related]
7. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.
Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS
Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472
[TBL] [Abstract][Full Text] [Related]
8. Contribution of decreased expression of Ku70 to enhanced radiosensitivity by sodium butyrate in glioblastoma cell line (U251).
Li Y; Zhou H; Xing E; Dassarath M; Ren J; Dong X; Liu H; Yang K; Wu G
J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):359. PubMed ID: 21671178
[TBL] [Abstract][Full Text] [Related]
9. AIM-2: a novel tumor antigen is expressed and presented by human glioma cells.
Liu G; Yu JS; Zeng G; Yin D; Xie D; Black KL; Ying H
J Immunother; 2004; 27(3):220-6. PubMed ID: 15076139
[TBL] [Abstract][Full Text] [Related]
10. DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining.
Douglas P; Gupta S; Morrice N; Meek K; Lees-Miller SP
DNA Repair (Amst); 2005 Aug; 4(9):1006-18. PubMed ID: 15941674
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer.
Alshareeda AT; Negm OH; Albarakati N; Green AR; Nolan C; Sultana R; Madhusudan S; Benhasouna A; Tighe P; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2013 Jun; 139(2):301-10. PubMed ID: 23624778
[TBL] [Abstract][Full Text] [Related]
12. Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation.
Ayene IS; Ford LP; Koch CJ
Mol Cancer Ther; 2005 Apr; 4(4):529-36. PubMed ID: 15827325
[TBL] [Abstract][Full Text] [Related]
13. Runx3 interacts with DNA repair protein Ku70.
Tanaka Y; Imamura J; Kanai F; Ichimura T; Isobe T; Koike M; Kudo Y; Tateishi K; Ikenoue T; Ijichi H; Yamaji Y; Yoshida H; Kawabe T; Omata M
Exp Cell Res; 2007 Sep; 313(15):3251-60. PubMed ID: 17662272
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells.
Tang J; Flomenberg P; Harshyne L; Kenyon L; Andrews DW
Clin Cancer Res; 2005 Jul; 11(14):5292-9. PubMed ID: 16033848
[TBL] [Abstract][Full Text] [Related]
15. The nuclear localization signal of the human Ku70 is a variant bipartite type recognized by the two components of nuclear pore-targeting complex.
Koike M; Ikuta T; Miyasaka T; Shiomi T
Exp Cell Res; 1999 Aug; 250(2):401-13. PubMed ID: 10413594
[TBL] [Abstract][Full Text] [Related]
16. The Ku70-binding site of Ku80 is required for the stabilization of Ku70 in the cytoplasm, for the nuclear translocation of Ku80, and for Ku80-dependent DNA repair.
Koike M; Koike A
Exp Cell Res; 2005 May; 305(2):266-76. PubMed ID: 15817152
[TBL] [Abstract][Full Text] [Related]
17. Ku80 can translocate to the nucleus independent of the translocation of Ku70 using its own nuclear localization signal.
Koike M; Ikuta T; Miyasaka T; Shiomi T
Oncogene; 1999 Dec; 18(52):7495-505. PubMed ID: 10602508
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated expression of a dominant negative Ku70 fragment radiosensitizes human tumor cells under aerobic and hypoxic conditions.
He F; Li L; Kim D; Wen B; Deng X; Gutin PH; Ling CC; Li GC
Cancer Res; 2007 Jan; 67(2):634-42. PubMed ID: 17234773
[TBL] [Abstract][Full Text] [Related]
19. Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas.
Shao CJ; Fu J; Shi HL; Mu YG; Chen ZP
J Neurooncol; 2008 Aug; 89(1):27-35. PubMed ID: 18415044
[TBL] [Abstract][Full Text] [Related]
20. KARP-1 works as a heterodimer with Ku70, but the function of KARP-1 cannot perfectly replace that of Ku80 in DSB repair.
Koike M; Yutoku Y; Koike A
Exp Cell Res; 2011 Oct; 317(16):2267-75. PubMed ID: 21756904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
